Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | Not yet disclosed by govt.Likely | 13 | - |
| 2 | Schedule 2 | Not yet disclosed by govt.Likely | 13 | - |
| 3 | Schedule 3 | SMPL LIFE SCIENCES PRIVATE LIMITEDLikely | 1 | ₹4,996 |
| 4 | Schedule 4 | CHEMO HEALTHCARE PRIVATE LIMITEDLikely | 1 | ₹79,335 |
| 5 | Schedule 5 | CHEMO HEALTHCARE PRIVATE LIMITEDLikely | 3 | ₹37,275 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
14 Jun 2025, 9:00 amClosed
NINTEDANIB 150 MG SOFT GELATIN CAPSULES
NOR- ETHISTERONE 5 MG TAB
TENOFOVIR 300 MG PLUS LAMIVUDINE 300 MG PLUS DOTUEGRAVIR 50 MG . FDC
PANTOPRAZOLE 40 MG PLUS ITOPRIDE 150 MG CAP
ZIDOVUDINE TAB 300 MG
7864792
GEM/2025/B/6252998
Two Packet Bid
NINTEDANIB 150 MG SOFT GELATIN CAPSULES
30 days
Maharashtra; Mumbai
Item wise evaluation
BOQ
6 documents required · 6 mandatory
2 yrs
₹3
20%
Exempted
14 Jun 2025
23 May 2025
14 Jun 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | NINTEDANIB 150 MG SOFT GELATIN CAPSULES | 4,800 | No | Mumbai | 30 |
| 2 | NOR-ETHISTERONE 5 MG TAB | 1,300 | No | Mumbai | 30 |
| 3 | TENOFOVIR 300 MG PLUS LAMIVUDINE 300 MG PLUS DOTUEGRAVIR 50 MG . FDC | 200 | No | Mumbai | 30 |
| 4 | PANTOPRAZOLE 40 MG PLUS ITOPRIDE 150 MG CAP | 36,900 | No | Mumbai | 30 |
| 5 | ZIDOVUDINE TAB 300 MG | 3,500 | No | Mumbai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7864792.pdf
GEM_BID
nintedanib_bbqr_2025-05-20-13-41-23_f81912f9bf334b67ff25730ea50c2066.pdf
BOQ
glimepride_2025-05-20-13-41-23_6248dd7c3bd2789ec30253a9d37f6b5c.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .